The Barbados Medicinal Cannabis Licensing Authority (BMCLA) is the sole regulator, that is mandated to create and position the local medicinal cannabis industry as a global centre of excellence in training, certification, research and development and to provide a high quality, accessible and advanced patient-centric environment to qualifying individuals.

The BMCLA also ensures that the safety of the public and consumers of medicinal cannabis and its by-products are adequately protected, by appropriately regulating the importation, sale, distribution, possession, purchase, manufacture, cultivation, transportation and exportation of medicinal cannabis.

• develops policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner;

• regulates the handling of medicinal cannabis;

• issues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Barbados Medicinal Industry Act;

• develops enforcement procedures in relation to the inspection of premises that are operated by a person in order to ensure compliance with the provisions of the Barbados Medicinal Industry Act or any regulations made pursuant to this Act;

• where required, assists with the provision of analytical services;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database to:

  • Collect, collate and include information relating to persons who handle medicinal cannabis or cannabis in accordance with this Act; and

  • Provide for the electronic tracking of the handling of medicinal cannabis or cannabis in accordance with the Barbados Medicinal Industry Act;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, requests from the Minister of Health such information as may assist the BMCLA with its functions;

• provides for the distribution of educational materials and the conduct of training programmes in relation to the development and use of medicinal cannabis and the medicinal cannabis industry;

• ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Barbados Medicinal Industry Act;

• performs such other functions assigned to it under the Barbados Medicinal Industry Act or any other enactment; and

• enters into any arrangement, which, in the opinion of the BMCLA, is necessary to ensure the proper performance of its functions.

Everyone's response to cannabis differs and can vary from one time to the next.

Like any other drug, cannabis can:

• Impair your ability to drive safely or operate heavy equipment
• It can cause drowsiness, slow reaction times, lower your ability to pay attention and impair coordination
• Affect your mental capacity
• Impair your concentration, memory and decision-making, and can impact your ability to perform well on the job or at school.[1]
• Cause euphoria (a high) it can also cause anxiety or panic.[2]
• In rare cases, cannabis can trigger a psychotic episode (not knowing what is real, experiencing paranoia, having disorganized thoughts and, in some cases, hallucinating).[3]

[1] [2] [3] World Health Organization (WHO). The health and social effects of nonmedical cannabis use.

Cannabinoids are chemicals which interact with the endocannabinoid system in mammals. These can be found in the Cannabis plant (phytocannabinoids), endogenously derived (endocannabinoids) or synthesised chemically. Research has found that the cannabis plant produces approximately 120 cannabinoids and about 300 non-cannabinoid chemicals. The two main clinically relevant cannabinoids are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The most commonly known of the two is delta-9-tetrahydrocannabinol (THC), which is the chemical that is primarily responsible for the psychoactive effects of cannabis.

The Barbados Medicinal Cannabis Licensing Authority grants licenses to facilitate the cultivation, processing, transport and dispensing of medicinal cannabis to patients. The Medicinal Cannabis Industry Act, 2019 outlines that medicinal cannabis products can be prescribed by a medical practitioner. A Pharmacy with a retail distributor's license can dispense medicinal cannabis when presented by a patient with a prescription and a valid form of identification.

Currently, there are five legally-approved medicinal cannabis drugs, placed on the National Drug Formulary for specific indications, via approval from the Minister of Health and Wellness utilising Section 12 of the Drug Abuse (Control and Prevention) Act Cap 131.

Please speak to your doctor or pharmacist for more information on accessing medicinal cannabis.

Cannabis use is discouraged during pregnancy and during nursing. Substances in cannabis can transfer from the mother to child and can affect your unborn or newborn baby.